市场调查报告书
商品编码
1422657
微创手术器械市场 - 产品(手持式器械、导引装置、电外科装置、辅助装置)、手术类型(心胸、胃肠、骨科、妇科)、最终用途和预测,2024-2032年Minimally Invasive Surgical Instrument Market - Product (Handheld Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices), Surgery Type (Cardiothoracic, Gastrointestinal, Orthopedic, Gynecological), End-use & Forecast, 2024-2032 |
由于医疗领域的技术进步,预计 2024 年至 2032 年微创手术器材市场的CAGR将超过 8.1%。全球慢性病盛行率的不断上升和人口老化的不断加剧,推动了对侵入性更小、更快、更安全的手术干预的需求。
根据联合国《世界人口展望》,到2022年,65岁以上人口接近7.71亿,几乎占全球总人口的10%。到2050年,老年人口比例预计将增加,达到总人口的16%。老年人更容易患各种慢性疾病和生活方式疾病。他们选择恢復时间快的微创手术,增加了相关手术器械的需求。
微创手术器械市场根据产品、手术类型、最终用途和地区进行分类。
预计到 2032 年,骨科手术领域对这些仪器的需求将会强劲,因为它们正在改变关节置换、关节镜检查和脊椎手术的模式。对更快恢復时间、减少术后疼痛和更小切口的需求推动了这些器械在骨科手术中的采用。外科医生和患者受益于精确度的提高和组织破坏的最小化,这标誌着骨科手术实施方式的范式转变。
预计到 2032 年,门诊手术中心 (ASC) 领域将大幅成长。ASC 提供的效率和成本效益使其成为对患者和医疗保健提供者都有吸引力的选择。微创手术与 ASC 的目标完美契合,提供了缩短週转时间、提高患者吞吐量并降低整体医疗成本的机会。 ASC 致力于确保更广泛的患者群体更容易接受微创手术。
由于强大的医疗基础设施和积极主动的技术整合,欧洲微创手术器材产业规模将在 2023 年至 2032 年期间大幅扩大。对先进技术的日益接受,加上门诊手术需求的不断增长,推动了产品需求。欧洲的支持性监管框架将为该地区的领导企业创造巨大的成长机会。
Minimally Invasive Surgical Instrument Market is anticipated to witness more than 8.1% CAGR between 2024 and 2032 owing to the technological advancements in medical sector. The increasing prevalence of chronic diseases and a growing aging population worldwide are propelling the need for less invasive, quicker, and safer surgical interventions.
As per the UN World Population Prospects, in 2022, there were nearly 771 million people aged 65 years or older which was almost 10% of the total global population. By 2050, the geriatric proportion is expected to increase, reaching 16% of the total population. The elderly are more susceptible to various chronic and lifestyle ailments. They opt for minimally invasive procedures with quick recovery time, bolstering the demand for related surgical instruments.
The minimally invasive surgical instruments market is classified based on product, surgery type, end-use, and region.
The orthopedic surgery segment is expected to record strong demand for these instruments through 2032 as they are transforming the landscape of joint replacements, arthroscopy, and spine surgeries. The demand for quicker recovery times, reduced postoperative pain, and smaller incisions has fueled the adoption of these instruments in orthopedic surgeries. Surgeons and patients are benefiting from enhanced precision and minimal tissue disruption, marking a paradigm shift in the way orthopedic procedures are performed.
The ambulatory surgical centers (ASCs) segment is anticipated to witness substantial growth through 2032. The efficiency and cost-effectiveness offered by ASCs make them an attractive option for both patients and healthcare providers. Minimally invasive procedures align perfectly with the goals of ASCs, providing the opportunity for quicker turnaround times, increased patient throughput, and reduced overall healthcare costs. The ASCs strive to ensure minimally invasive procedures are more accessible to a broader patient base.
Europe minimally invasive surgical instruments industry size will expand significantly over 2023-2032, due to robust healthcare infrastructure and a proactive approach towards technological integration. The growing acceptance of advanced technologies, coupled with the rising demand for outpatient procedures, fuel the product demand. The supportive regulatory frameworks in Europe will create massive growth opportunities for leading players in the region.